Séné Tamarin Guimauve
Food supplement declared in France, declaration No 2021-12-1024
Séné Tamarin Guimauve is a food supplement declared in France. Status: retrait du marché annoncé pour le 1 September 2027. 1 point in its composition requires a check (prohibited substance, dose or novel food). 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- Laboratoires VITARMONYL
- Status
- Retrait du marché annoncé pour le 1 September 2027
- Form
- Gélule
- Daily dose
- 1 gélule
- Directions for use
- Le soir au coucher, à avaler avec un verre d'eau
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an), Utilisation prolongée, Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)
- Objectives stated by the manufacturer (these are not authorised claims)
- Transit
Declaration 230174, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
Contains a preparation of senna (Cassia senna) (feuille). Preparations from this plant part containing hydroxyanthracene derivatives are under Union scrutiny (Annex III, Part C): a draft regulation sent to the Council on 15 July 2026 would prohibit them, with 12 months to sell through products already on the market. Their content is not declared.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie C (règlement (UE) 2021/468) ; projet de la Commission D099926/3.
- Conditions légales
Senna alexandrina Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retrait du marché annoncé pour le 1 September 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Tamarindus indica L. | Fruit (pulpe) | Extrait sec hydroalcoolique | 120 mg |
| Senna alexandrina Mill. | Feuille | Extrait sec hydroalcoolique | 75 mg |
| Althaea officinalis L. | Racine | Extrait sec aqueux | 25 mg |
Additives
E460, E470b
Other ingredients
Gélule végétale, maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé en cas d'allergie à l'un des constituants
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.